Avalo Therapeutics (AVTX) vs Obsidian Therapeutics (OBX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Obsidian Therapeutics is the larger company by market cap ($756.1 million vs $720.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVTX | OBX |
|---|---|---|
| Share price | $13.43 | $12.24 |
| Market cap | $720.25M | $756.10M |
| 1-day change | -1.10% | -7.27% |
| YTD return | -26.05% | — |
| 1-year return | -5.56% | — |
| 5-year return | -99.79% | — |
| EPS (TTM) | $-4.31 | $-1.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $24.27 | $49.97 |
| 52-week low | $12.51 | $12.09 |
| Distance from 52-week high | -44.66% | -75.51% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +228.22% | +218.63% |
| Average volume | 926.15K | 364.47K |
| Shares outstanding | 53.63M | 61.77M |
| Employees | 33 | 87 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Avalo Therapeutics
AVTX stock →Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 33 employees
About Obsidian Therapeutics
OBX stock →Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
AVTX vs OBX FAQ
Which is bigger, Avalo Therapeutics or Obsidian Therapeutics?
Obsidian Therapeutics (OBX) is larger, with a market capitalization of $756.10M compared with $720.25M for Avalo Therapeutics (AVTX).
Are Avalo Therapeutics and Obsidian Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.